Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 4 3Phase 2 3Phase 2/3 2

Status

Completed 37Terminated 11Unknown 3Withdrawn 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1

Conditions

Lung Neoplasms 1Carcinoma, Hepatocellular 1Bone Metastatic Non-small Cell Lung Cancer 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Zoledronic Acid × Clear all
NCT04325776 2020-10-12

A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 2 Unknown
60 enrolled
Thoracic

Bone Metastatic Non-small Cell Lung Cancer

NCT01737216 2012-12-31

Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer

Hebei Tumor Hospital

Phase 2 Unknown
100 enrolled
Thoracic

Lung Neoplasms

NCT01259193 2011-04-14

Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC

Fudan University

Phase 2 Unknown
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡